Table 5.

Studies investigating the ability of CCTA for the assessment of clinical outcomes by evaluation of (A) coronary artery stenosis and (B) atherosclerotic plaque.

Study	Number of patients	Median follow-up time (years)	Event rate in all patients (%)	Event rate in CT positive patients (%)	Event rate in CT negative patients (%)	Hazard ratios
(A) PREDICTION OF OUTCOMES BY CORONARY ARTERY STENOSIS
Pundziute et al., 2007	100	2.2	26	58	8	28.0
Gaemperli et al., 2008	220	1.2	23	51	2	12.7
Carrigan et al., 2009	227	2.3	3.5	13	0.5	9.8
Gopal et al., 2009	493	3.3	1.2	6.5	0.1	16.6
Hadamitzky et al., 2009	1150	1.5	1.2	3.3	0.3	16.1
Aldrovandi et al., 2009	187	2.0	5.4	24.3	1.0	34.9
Rubinshtein et al., 2009	545	1.5	6.4	14.5	1.0	10.9
van Werkhoven et al., 2009b	432	1.8	2.9	6.5	2.5	3.6
van Werkhoven et al., 2009a	316	1.8	2.2	6.0	1.7	3.5
Andreini et al., 2012	1304	4.3	2.6	19.9	0	4.8
Motoyama et al., 2009	1059	2.6	0.8	22.3	0.5	22.8
Hadamitzky et al., 2011	2223	2.3	0.9	2.9	0.3	13.5
(B) PREDICTION OF OUTCOMES BY CORONARY PLAQUE
Pundziute et al., 2007	100	2.2	24	30	0	n.a.
Gaemperli et al., 2008	220	1.2	23	28	0	n.a.
Ostrom et al., 2008	2538	6.5	0.5	0.72	0.26	n.a.
van Werkhoven et al., 2009b	432	1.8	1.9	4.9	1.4	n.a.
van Werkhoven et al., 2009a	316	1.8	1.3	3.5	0.64	n.a.